Patents Assigned to VIE, INC.
  • Publication number: 20230183339
    Abstract: Aspects of the application provide anti-hemojuvelin antibodies and methods of using the same in treating anemias of chronic disease, iron-restricted anemias, and/or conditions associated with anemia.
    Type: Application
    Filed: May 13, 2021
    Publication date: June 15, 2023
    Applicants: Disc Medicine, Inc., Abb Vie Deutschland GmbH & Co. KG, Abb Vie Inc.
    Inventors: Maria Beconi, John Quisel, Brian MacDonald, Steven Robinette, Bernhard Mueller, Andreas Popp, Jennifer M. Perez
  • Patent number: 10316338
    Abstract: Disclosed are methods of synthesizing enantioenriched difluoroalkylcyclopropyl amino esters and their salts, such as the dicyclohexylamine salt of (1S,2R)-2-(difluoromethyl)-1-(propoxycarbonyl)cyclopropane carboxylic acid. These compounds are useful intermediates in the synthesis of viral protease inhibitors.
    Type: Grant
    Filed: January 29, 2016
    Date of Patent: June 11, 2019
    Assignee: Abb Vie Inc.
    Inventors: Michael J. Abrahamson, Angelica B. Kielbus, William T. Riordan, David R. Hill, Sanjay R. Chemburkar, Rajarathnam E. Reddy, Timothy B. Towne, Jianzhang Mei, Gareth J. Brown, Stefan Mix
  • Patent number: 9951084
    Abstract: The present invention relates spiro-cyclic amine derivatives of the formula (1) wherein R1; R2; R3; Q; —W-T-; R5; Z; and A have the definitions provided in the claims; or a pharmaceutically acceptable salt, a solvate or hydrate thereof or one or more N-oxides thereof. The compounds of the invention have affinity to S1P receptors and may be used in the treatment, alleviation or prevention of diseases and conditions in which (a) S1P receptor (s) is (are) involved.
    Type: Grant
    Filed: August 5, 2016
    Date of Patent: April 24, 2018
    Assignees: Abb Vie B.V., Abb Vie, Inc.
    Inventors: Axel Stoit, Wouter I. Iwema Bakker, Hein K. A. C. Coolen, Maria J. P. van Dongen, Nicolas J.-L. D. Leflemme, Adrian Hobson
  • Patent number: 9299077
    Abstract: A method and apparatus enabling the distribution of hyper-relevant advertising to consumers who have confirmed interests in specific content, products, and services is described. Users define “who they are” and “what they want” in a spontaneous, guided, voluntary disclosure of rich, candid, personal information conceived to attract individuals who seek or share common relationships, experiences, objectives, skills, knowledge, acquaintances, interests, needs, or desires for mutual gain. The information is converted into encrypted user codes; these codes are used to generate precisely controlled electronic encounters, the creation and delivery of highly personalized hyper-relevant advertising, and the gathering of amounts of research data through the ad hoc interaction of unique mobile devices.
    Type: Grant
    Filed: October 25, 2006
    Date of Patent: March 29, 2016
    Assignee: VIE, INC.
    Inventor: Curtis M. Brubaker